FMC
OTLK icon

First Merchants Corp’s Outlook Therapeutics OTLK Stock Holding History

First Merchants Corp’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,459
Closed -$58.2K – 225
2023
Q4 		$58.2K Hold
7,459
– – ﹤0.01% 211
2023
Q3 		$32.8K Hold
7,459
– – ﹤0.01% 204
2023
Q2 		$260K Hold
7,459
– – 0.02% 191
2023
Q1 		$161K Hold
7,459
– – 0.01% 213
2022
Q4 		$160K Hold
7,459
– – 0.01% 223
2022
Q3 		$182K Hold
7,459
– – 0.02% 218
2022
Q2 		$151K Buy
7,459
+2,320
+45% +$66.7K 0.01% 217
2022
Q1 		$182K Buy
5,139
+3,437
+202% +$107K 0.01% 230
2021
Q4 		$46K Buy
+1,702
New +$60.7K ﹤0.01% 235

Other funds holding OTLK

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

First Merchants Corp's OTLK Position: Q1 2024 in Review

First Merchants Corp sold out of Outlook Therapeutics (OTLK) in Q1 2024, closing a stake of 7,459 shares — an estimated $58.2K sold.

First Merchants Corp first reported a position in OTLK in Q4 2021 and held it in 9 quarters. The position peaked at $260K in Q2 2023. 56 funds tracked by Wall St. Rank hold OTLK as of Q1 2024.

  • First Merchants Corp reported no remaining Outlook Therapeutics position as of Q1 2024 after selling out during the quarter.
  • First Merchants Corp sold 7,459 Outlook Therapeutics shares in Q1 2024, an estimated $58.2K.
  • First Merchants Corp first reported a position in Outlook Therapeutics in Q4 2021 and held it in 9 quarters.
  • First Merchants Corp's Outlook Therapeutics position peaked at $260K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2024.

Based on First Merchants Corp's 13F filing for Q1 2024, filed 25 Apr 2024.